Variant report
Variant | nsv523087 |
---|---|
Chromosome Location | chr1:179352736-179371973 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4077551 | chr1:179352736-179352737 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539948453 | chr1:179352755-179352756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559946237 | chr1:179352756-179352757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190419366 | chr1:179352787-179352788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542099757 | chr1:179352822-179352823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs370927403 | chr1:179352824-179352825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4077552 | chr1:179352925-179352926 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs531262286 | chr1:179352936-179352937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566526534 | chr1:179352969-179352970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551269528 | chr1:179353023-179353024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564490747 | chr1:179353030-179353031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533326197 | chr1:179353048-179353049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546967413 | chr1:179353095-179353096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182950306 | chr1:179353112-179353113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148289549 | chr1:179353131-179353132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538279957 | chr1:179353149-179353150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572965160 | chr1:179353157-179353158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548931004 | chr1:179353160-179353161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568683959 | chr1:179353196-179353197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373017871 | chr1:179353239-179353240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537763611 | chr1:179353258-179353259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538414583 | chr1:179353310-179353311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557589830 | chr1:179353325-179353326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113236169 | chr1:179353333-179353334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533600884 | chr1:179353338-179353339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553721013 | chr1:179353394-179353395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76206816 | chr1:179353424-179353425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35978436 | chr1:179353439-179353440 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs4261076 | chr1:179353440-179353441 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs74130195 | chr1:179353476-179353477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79992940 | chr1:179353508-179353509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187102730 | chr1:179353555-179353556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557182911 | chr1:179353609-179353610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564815763 | chr1:179353618-179353619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150667958 | chr1:179353670-179353671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534496896 | chr1:179353751-179353752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111535666 | chr1:179353769-179353770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139851676 | chr1:179353787-179353788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553124847 | chr1:179358619-179358620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573092165 | chr1:179358623-179358624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11807559 | chr1:179358626-179358627 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs187795353 | chr1:179358646-179358647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34338301 | chr1:179358683-179358684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145614892 | chr1:179358698-179358699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370640694 | chr1:179358787-179358788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192617613 | chr1:179358791-179358792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184965439 | chr1:179358816-179358817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577656064 | chr1:179358824-179358825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546113766 | chr1:179358873-179358874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559875521 | chr1:179358887-179358888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 23248035 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:179352600-179353800 | Enhancers | HepG2 | liver |
2 | chr1:179358600-179359400 | Enhancers | Ovary | ovary |
3 | chr1:179366600-179367000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr1:179367200-179367600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:179367200-179367600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr1:179367600-179368200 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr1:179367800-179368000 | Enhancers | Pancreas | Pancrea |
8 | chr1:179367800-179368200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:179368000-179368200 | ZNF genes & repeats | Pancreas | Pancrea |